Eugene Athan

11.8k citations
214 papers · 8.7k · 6 hit papers · h-index 45

Impact in

  • Epidemiology top 0.5%
    • Infective Endocarditis Diagnosis and Management
    • Mycobacterium research and diagnosis
    • Herpesvirus Infections and Treatments
    • Respiratory viral infections research
    • Antibiotic Use and Resistance

Papers in

    • Mycobacterium research and diagnosis 40
    • Infective Endocarditis Diagnosis and Management 31
    • Herpesvirus Infections and Treatments 9
    • Antimicrobial Resistance in Staphylococcus 12
    • Infection Control in Healthcare 9
    • Antifungal resistance and susceptibility 7

Eugene Athan

198 papers receiving 8.2k citations

Eugene Athan's Hit Papers

Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial 2025 · 34 citations
340+7+14Years since publication250500750

Peers

Eugene Athan
Comparison fields: 5 of 140
  • Epidemiology 4.4k
  • Applied Microbiology and Biotechnology 271
  • Molecular Medicine 658
  • Infectious Diseases 1.6k
  • Microbiology 75
Replace José María Aguado with:
José María Aguado Spain
Mª Carmen Fariñas Spain
Tony M. Korman Australia
Jesús Fortün Spain
Sang‐Oh Lee South Korea
Catia Cillóniz Spain
Mario Fernández‐Ruiz Spain
Jun Hee Woo South Korea
Louis Bernard France
N. Deborah Friedman Australia
Eugene Athan relative to José María Aguado Spain José María Aguado's profile →
Citations per field
00.5×1.6×
José María Aguado · 1×
Citations per year

Countries citing papers authored by Eugene Athan

Since Specialization
Citations

This map shows the geographic impact of Eugene Athan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Athan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Athan more than expected).

Fields of papers citing papers by Eugene Athan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Athan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Athan. The network helps show where Eugene Athan may publish in the future.

Co-authors

The 25 scholars most cited alongside Eugene Athan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eugene Athan Line = papers co-authored together Eugene Athan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 214 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Staphylococcus aureus Endocarditis
Hit paper breakdown →
2005939
2
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Hit paper breakdown →
2016831
3
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance
Hit paper breakdown →
2018612
4
The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria
Hit paper breakdown →
2023411
5 2014228
6 2016164
7 2008161
8 2015155
9 2007145
10 2013135
11 2020131
12 2020125
13
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons
Hit paper breakdown →
2024117
14 2023103
15 201695
16 200794
17 201694
18 201583
19 202281
20 202080

About Eugene Athan

Eugene Athan is a scholar working on Epidemiology, Infectious Diseases, Applied Microbiology and Biotechnology, Molecular Medicine and Microbiology, having authored 214 papers that have together received 8.7k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (40 papers), Infective Endocarditis Diagnosis and Management (31 papers), Antimicrobial Resistance in Staphylococcus (12 papers), Antibiotic Resistance in Bacteria (11 papers), Antibiotic Use and Resistance (11 papers), Infection Control in Healthcare (9 papers), Herpesvirus Infections and Treatments (9 papers) and Antifungal resistance and susceptibility (7 papers). The work is most often cited by research in Epidemiology (4.4k citations), Applied Microbiology and Biotechnology (271 citations), Molecular Medicine (658 citations), Infectious Diseases (1.6k citations) and Microbiology (75 citations). Eugene Athan has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Daniel Patrick O'Brien, N. Deborah Friedman, Andrew Jerome Hughes, Anthony McDonald, Andrew J. Hughes, Peter Callan, Aaron Walton, Paul D. R. Johnson, Vivian H. Chu and José Maria Miró. Their work appears in journals such as The Medical Journal of Australia, Clinical Infectious Diseases, Emerging infectious diseases, PLoS neglected tropical diseases and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact